premarin vag cream 0.625mg
wyeth - estrogens conjugated equine - cream - 0.0625 %
gynest 0.01% cream
marlborough pharmaceuticals ltd - estriol - vaginal cream - 100microgram/1gram
gynest 0.01% cream
marlborough pharmaceuticals ltd - estriol - vaginal cream - 100microgram/1gram
ovestin 1mg cream
de pharmaceuticals - estriol - vaginal cream - 1mg/1gram
ovestin 1mg cream
waymade healthcare plc - estriol - vaginal cream - 1mg/1gram
ovestin 1mg cream
dowelhurst ltd - estriol - vaginal cream - 1mg/1gram
ovestin 1mg cream
sigma pharmaceuticals plc - estriol - vaginal cream - 1mg/1gram
ovestin 1mg cream
mawdsley-brooks & company ltd - estriol - vaginal cream - 1mg/1gram
menest- estrogens, esterified tablet
physicians total care, inc. - estrogens, esterified (unii: 3asp8q3768) (estrogens, esterified - unii:3asp8q3768) - estrogens, esterified 0.3 mg - menest is indicated in the: - treatment of moderate to severe vasomotor symptoms associated with the menopause. treatment of moderate to severe vasomotor symptoms associated with the menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - female hypogonadism. female hypogonadism. - female castration. female castration. - primary ovarian failure. primary ovarian failure. - breast cancer (for palliation only) in appropriately selected women and men with metastatic disease. breast cancer (for palliation only) in appropriately selected women and men with metastatic disease
premphase- conjugated estrogens and medroxyprogesterone acetate kit
physicians total care, inc. - estrogens, conjugated (unii: iu5qr144qx) (estrogens, conjugated - unii:iu5qr144qx), medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - estrogens, conjugated 0.625 mg - prempro or premphase therapy should not be used in women with any of the following conditions: - undiagnosed abnormal genital bleeding - known, suspected, or history of breast cancer - known or suspected estrogen-dependent neoplasia - active deep vein thrombosis, pulmonary embolism or a history of these conditions - active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions - known liver dysfunction or disease - known thrombophilic disorders (e.g., protein c, protein s, or antithrombin deficiency) - known or suspected pregnancy prempro and premphase should not be used during pregnancy [see contraindications (4)] . there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins as an oral contraceptive inadvertently during early pregnancy. prempro and premphase should not be used during lactation. estrogen administration to nursing mothers has been shown to decrease the quanti